This study confirms that INOS is involved in NAFLD progression by influencing macrophage‐mediated changes in lipid metabolism and autophagy, providing a new research basis for treating NAFLD. The gene discussed is NOS2; the disease is metabolic dysfunction-associated steatotic liver disease.